rfhg_123764.1

Basic information about the TSS

---

TSS ID: rfhg_123764.1 Species: human Chr: chr10		Start: 22714532 End: 22714633 Strand: -
Source datasets	PRJNA401781|PRJNA615891|PRJNA4843412|DRA013844
Protocol	CAGE|SLIC_CAGE|NETCAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2323940,EH38E1454766)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000376573.9:0 BC018034:0 GeneID: 5305 HGNC/MGI_ID: HGNC:8997 UniProt_ID: P48426 Nearer transcript ids and distances: S78798:72 U14957:184 CU676140:205 ENST00000545335.5:424 NM_001330062.2:424 AK294817:424 view more...

Gene_name: phosphatidylinositol-5-phosphate 4-kinase type 2 alpha Gene_symbol: PIP4K2A Gene_synonyms: PIP5KIIA PIP5KIIalpha Gene_source: HGNC:8997

TATA-Box annotation

---

Distance to TSS:	-4
Nearest PromoterID:	NM_005028
Entrez ID:	5305
Nearest Unigene:	Hs.57079
Nearest Refseq:	NM_005028
Nearest Ensembl:	ENSG00000150867
Gene Name:	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
Gene Alias:	PI5P4KA|PIP5K2A|PIP5KII-alpha|PIP5KIIA|PIPK
Gene Type:	protein-coding
CpG%:	0.217822
GC%:	0.803922
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PIP4K2A p2@PIP4K2A p3@PIP4K2A p4@PIP4K2A p5@PIP4K2A
Sample		p1@PIP4K2A	p2@PIP4K2A	p3@PIP4K2A	p4@PIP4K2A	p5@PIP4K2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.69	4.48	1.36	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.56	2.83	1.42	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.47	4.63	0.58	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.36	1.87	1.25	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.92	2.47	1.57	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.66	3.49	0.97	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.33	3.05	0.87	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.51	2.42	0.24	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.47	3.42	0.21	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	1.74	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.66	1.21	0.40	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	2.85	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.03	6.93	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.07	6.77	1.05	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.90	8.56	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.54	6.79	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.12	6.55	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.33	8.44	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	2.13	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.08	7.97	0.45	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.02	6.28	0.94	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.32	6.90	0.69	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.40	4.78	1.16	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.55	6.31	0.49	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	7.22	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	6.65	0.95	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.24	7.69	1.10	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	5.42	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.24	6.14	0.81	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.32	6.33	0.72	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.02	5.02	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.52	5.47	0.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4.22	3.80	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.73	7.09	0.33	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	4.86	5.80	0.37	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.43	4.98	1.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.77	5.93	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.07	5.24	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	5.13	4.59	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.44	4.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.88	5.41	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.42	3.07	0.59	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.69	4.22	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.82	2.80	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.83	3.21	0.80	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	5.12	0.47	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.44	3.36	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.96	1.79	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.46	4.55	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.86	5.26	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.17	5.12	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.34	8.01	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	1287.28	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.32	4.26	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.97	1.99	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	42.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.51	7.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.54	4.21	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.78	5.14	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	13.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	2.82	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	4.49	5.05	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	33.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.10	9.85	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.22	9.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.26	6.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	1664.89	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	608.11	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.41	2.93	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	2.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.63	2.35	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.96	8.28	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.50	5.57	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.03	6.42	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	24.71	19.16	2.38	0.79	0.48
Adipocyte - breast, donor2	11327-117E4	12.99	15.08	0.64	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	24.30	18.96	3.18	0.76	0.51
Adipocyte - omental, donor2	11474-119C7	17.19	7.47	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	10.72	4.35	0.67	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.29	9.57	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	9.03	1.35	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	8.69	7.82	0.70	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	29.53	14.08	2.15	1.17	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	19.56	6.95	1.54	1.03	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.27	8.36	3.35	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	3.53	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.13	7.48	2.49	0.56	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	20.01	13.88	1.29	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	9.60	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	5.01	1.67	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	6.65	1.66	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	11.55	1.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	5.56	1.64	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	9.13	2.74	0.91	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	7.07	1.99	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.28	1.80	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.57	3.29	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	12.47	7.67	0.69	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	9.80	1.96	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	7.19	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.21	6.95	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	10.70	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.07	5.38	2.09	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	11.38	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	9.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	7.15	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	5.34	2.91	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	3.56	8.91	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.68	10.92	1.13	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	11.61	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	7.52	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.40	5.44	0.49	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	5.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.50	6.33	0.90	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	6.43	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.20	6.23	0.94	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.89	8.02	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.96	11.44	1.16	0.33	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	7.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.12	8.92	1.72	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	16.78	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	9.71	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.83	9.87	1.52	1.52	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	4.85	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	6.27	0.00	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.83	8.34	1.07	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.97	9.03	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	7.04	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.32	13.83	1.61	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	4.99	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.19	12.87	0.58	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.54	13.55	0.60	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	11.88	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	7.63	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.15	13.50	0.76	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	11.44	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.79	9.06	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.22	7.83	1.27	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	9.57	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	9.45	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.17	9.32	0.85	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	13.90	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	8.45	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	11.36	8.36	1.72	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	9.63	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	2.92	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.51	8.28	1.38	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	15.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.14	6.36	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.43	8.05	1.65	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	10.40	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	11.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.09	8.87	1.11	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	12.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	5.54	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	7.68	0.26	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	5.45	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.47	4.91	1.23	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.84	2.91	0.51	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	9.44	3.36	0.84	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	33.46	17.43	2.44	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	44.16	18.12	5.18	0.49	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	33.11	16.86	2.39	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	95.76	76.04	6.88	2.06	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	96.09	73.29	7.39	0.88	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	83.30	63.38	5.92	1.25	1.14
Basophils, donor1	12241-129G9	72.18	18.57	14.38	4.18	1.05
Basophils, donor2	12242-129H1	129.89	50.51	24.89	9.38	1.08
Basophils, donor3	12243-129H2	63.80	28.37	15.29	3.23	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.53	0.65	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.66	1.04	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.45	1.84	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	2.70	3.42	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	41.12	49.36	3.40	0.72	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	61.49	58.69	6.06	1.40	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	45.41	20.15	1.92	1.28	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	68.19	25.36	12.96	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	45.29	27.47	7.24	3.34	0.37
CD14+ Monocytes, donor3	11381-118B4	62.13	37.76	14.71	3.07	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.25	19.25	5.09	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.14	16.30	7.96	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.69	21.37	3.62	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	36.43	21.68	4.77	1.73	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	23.23	9.35	3.32	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	34.82	12.79	5.45	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.09	10.21	3.85	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.01	9.66	6.62	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.79	11.65	2.48	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.15	18.01	4.50	1.57	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.26	11.04	4.63	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.33	11.75	4.13	0.87	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	18.50	9.60	2.81	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.90	8.98	3.17	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	3.33	5.55	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	24.84	15.17	3.42	0.59	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.15	11.57	3.19	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	27.07	8.95	4.79	1.46	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	31.11	16.24	3.20	1.14	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	17.64	4.98	4.30	1.36	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.02	7.86	1.75	0.87	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.54	14.79	5.11	0.54	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.64	22.51	5.58	1.57	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	39.56	13.05	7.57	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	19.11	12.68	3.31	0.92	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	18.67	5.64	3.17	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	22.37	3.51	4.39	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.29	20.75	2.79	1.39	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.42	13.01	4.09	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	31.69	8.62	3.23	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.16	13.92	6.55	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.99	3.01	2.32	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.86	4.41	1.39	0.70	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	37.05	23.76	2.83	0.87	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	39.04	24.72	5.31	0.69	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	37.04	16.68	2.82	0.65	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	45.94	25.85	5.29	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	33.01	21.48	5.41	0.87	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	62.65	14.49	4.24	2.23	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	45.17	17.86	5.10	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	49.84	25.69	5.71	1.76	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	44.21	17.90	8.21	1.47	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	24.39	8.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	82.71	21.02	5.42	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	80.78	27.96	5.18	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	85.29	37.85	6.93	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	106.14	38.60	5.90	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	75.81	23.16	9.13	4.21	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	69.81	18.82	4.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	26.37	3.95	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	47.67	55.07	7.40	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	45.70	29.02	7.25	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	41.90	25.75	3.03	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	310.32	133.74	20.20	2.02	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	236.50	136.63	12.38	3.20	3.99
CD34+ Progenitors, donor1	11545-120B6	27.11	3.01	4.02	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	44.94	6.18	9.55	3.93	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	65.38	27.81	5.64	0.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	62.23	20.97	4.51	1.13	0.68
CD4+ T Cells, donor1	11225-116C1	127.83	52.49	18.92	4.28	1.07
CD4+ T Cells, donor2	11306-117C1	107.16	84.51	11.63	5.51	1.84
CD4+ T Cells, donor3	11382-118B5	129.62	113.15	22.26	6.10	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	60.75	17.10	5.10	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	56.37	41.33	3.14	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	62.09	26.45	3.74	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	95.29	21.81	10.90	3.79	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	110.26	26.69	6.32	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	29.67	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	49.86	30.49	5.20	1.45	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.33	56.60	5.08	1.53	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	56.42	42.56	4.35	0.81	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.59	50.21	13.90	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.35	45.07	15.72	3.14	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	109.56	38.28	18.48	1.76	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	90.23	53.55	13.07	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	92.67	103.68	12.67	3.12	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	79.86	72.51	10.69	1.00	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	103.06	44.05	7.89	2.45	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	107.19	43.41	13.93	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	102.21	48.42	10.76	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	100.13	50.62	14.65	2.97	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	84.91	43.76	11.48	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	99.61	45.60	17.65	1.47	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	96.57	24.27	19.21	2.53	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	126.94	31.63	19.50	2.17	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	154.28	49.25	21.79	3.92	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	215.76	67.80	31.18	6.93	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	217.87	45.24	34.16	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	231.71	60.02	39.08	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	220.99	35.72	31.85	5.26	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	265.27	43.19	48.83	4.91	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	218.68	55.44	35.42	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	240.30	66.25	40.47	8.95	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	286.69	87.25	54.01	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	195.78	106.08	49.44	11.46	1.64
CD8+ T Cells, donor2	11307-117C2	128.40	107.00	21.02	8.26	4.51
CD8+ T Cells, donor3	11383-118B6	183.05	130.28	36.86	12.12	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.32	4.36	0.23	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.91	4.31	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.21	6.02	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.00	4.20	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.04	4.08	0.24	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.41	4.09	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.69	2.17	0.65	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.74	5.53	0.53	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.68	5.63	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.25	2.42	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.84	5.81	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.26	2.66	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	3.50	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	4.10	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	2.98	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.44	3.96	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.06	5.18	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.49	4.48	0.71	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.68	4.75	0.95	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.69	4.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	5.13	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	4.21	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	2.76	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	2.27	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	4.01	2.41	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	7.69	3.50	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	3.01	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	14.62	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	10.87	9.39	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	13.26	7.68	0.63	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	11.09	6.24	0.69	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	7.82	3.91	1.78	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	12.29	10.47	1.37	0.23	0.68
Chondrocyte - re diff, donor2	11339-117F7	8.06	7.16	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	3.64	1.21	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	20.77	10.79	0.92	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	13.04	8.98	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.03	7.70	0.97	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	62.17	17.79	6.60	1.56	0.18
Corneal Epithelial Cells, donor1	11526-119I5	3.29	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.60	1.79	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.42	18.00	5.45	2.48	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.21	18.29	7.25	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	34.88	18.03	4.10	1.19	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	101.81	38.95	6.83	1.02	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	81.61	15.02	4.57	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	57.11	7.74	6.29	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	16.18	3.00	1.00	1.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.14	2.83	1.13	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.37	1.97	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.53	2.91	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.41	8.23	0.47	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	11.75	3.16	1.75	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.41	3.99	1.55	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.73	6.09	1.83	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.58	5.07	2.54	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	9.81	5.65	1.49	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	9.89	3.64	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.01	8.65	0.99	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	12.00	8.00	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	4.72	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.46	15.16	1.74	0.62	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	25.64	3.91	1.30	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.14	3.30	2.08	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	15.93	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	0.00	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.82	3.61	1.10	0.16	0.31
Eosinophils, donor1	12244-129H3	335.43	30.49	45.74	60.99	0.00
Eosinophils, donor2	12245-129H4	108.92	11.55	9.90	6.60	0.00
Eosinophils, donor3	12246-129H5	89.17	0.00	17.83	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.24	12.73	1.64	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.81	7.66	1.42	0.33	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.93	15.49	1.63	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.92	10.67	0.73	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.43	5.73	2.32	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.14	15.71	2.32	0.32	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.28	1.84	0.79	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.22	22.92	1.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	10.43	4.54	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	6.82	3.79	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	10.09	8.20	1.26	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	30.31	6.67	2.42	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	20.30	5.71	1.14	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	15.31	5.31	0.76	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.86	3.89	1.74	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	8.63	2.16	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	11.72	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	20.53	6.23	1.85	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	18.83	13.23	2.04	0.68	0.34
Fibroblast - Dermal, donor1	11269-116G9	7.75	2.58	1.41	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	14.15	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.39	11.24	1.45	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	15.60	6.44	1.02	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	14.83	5.93	1.22	0.17	0.52
Fibroblast - Dermal, donor6	11458-119A9	16.73	6.17	0.65	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.32	10.62	0.83	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.96	5.50	1.05	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	17.40	13.57	1.45	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	21.27	7.64	2.42	0.48	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	15.58	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.09	9.87	0.53	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.21	5.14	0.78	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.36	3.52	0.27	0.81	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	17.29	1.06	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.84	6.87	0.73	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.82	3.95	1.91	0.82	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.57	4.72	2.19	0.55	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.51	6.31	1.03	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	13.59	4.08	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	5.97	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	17.52	12.24	1.27	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	19.16	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	2.80	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.60	2.24	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	21.11	0.41	1.22	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	11.98	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.98	15.52	0.19	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.30	6.67	0.61	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	17.44	3.37	0.92	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.03	6.49	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.50	8.37	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.64	4.99	1.39	0.35	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.92	11.05	0.55	0.22	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.69	5.28	1.02	0.81	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	3.34	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	4.74	1.19	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	11.11	2.78	0.99	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.99	3.55	0.36	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.04	5.72	1.18	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.33	2.11	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.95	4.53	1.51	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.85	1.77	1.01	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	11.32	6.23	0.98	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	27.27	6.02	2.61	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	16.98	5.63	0.90	0.10	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	16.62	1.21	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.76	5.47	1.08	0.33	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.24	4.62	0.85	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.54	1.97	0.33	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.30	8.10	0.75	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	14.68	4.72	1.01	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.45	10.82	0.63	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	1639.82	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	1.74	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.05	4.51	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.03	3.12	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.96	3.58	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	16.08	3.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	15.95	15.95	1.91	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	50.49	41.93	4.28	0.29	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.12	39.98	2.48	0.28	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.03	20.09	0.23	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	33.88	40.62	2.77	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.09	34.63	1.59	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.83	14.02	2.28	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.11	27.86	2.65	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.77	10.60	0.99	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.75	7.39	1.60	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.92	13.70	1.07	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.41	15.86	1.24	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.30	8.31	1.52	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	9.15	1.83	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.60	12.32	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.57	7.97	0.62	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	15.30	5.25	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	17.14	12.71	1.48	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	17.96	8.11	1.59	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.63	8.04	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.95	11.29	2.22	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	19.51	10.18	1.02	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	17.56	6.03	1.51	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.25	13.32	1.25	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.15	6.32	1.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.36	7.41	1.33	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.30	9.57	0.67	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.54	3.88	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.03	9.70	1.03	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.52	9.45	1.38	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.85	11.84	2.00	1.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.75	14.55	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.05	9.96	1.48	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.10	8.92	1.13	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.60	18.60	1.28	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.38	6.63	1.23	0.47	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.52	14.71	3.80	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.77	13.68	2.43	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.59	12.86	2.09	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.08	13.83	3.07	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	16.55	14.03	1.68	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.15	8.15	3.06	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.92	12.03	2.14	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.58	15.30	1.84	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.43	10.10	2.59	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.29	12.20	4.07	0.54	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.25	14.20	2.40	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.34	14.04	3.73	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	32.73	12.89	3.97	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.13	12.53	2.24	0.26	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.97	11.50	0.81	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.20	11.18	3.30	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	34.24	10.75	1.79	0.20	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.11	9.71	1.23	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	38.26	9.41	1.84	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	8.14	4.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.93	7.06	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.06	17.53	1.84	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	12.37	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.54	10.06	1.16	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	16.04	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	5.22	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.60	9.44	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.71	6.59	1.24	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.58	7.83	1.40	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	10.79	7.19	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.07	23.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.77	9.86	0.64	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.00	9.51	0.68	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	0.00	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.91	14.89	1.72	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.10	16.87	0.89	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	11.86	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.81	17.81	2.49	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.34	11.97	1.15	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.07	12.69	1.15	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.65	12.06	2.28	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	8.69	3.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.50	12.71	0.77	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.59	17.80	2.74	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	37.27	7.45	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.18	8.49	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.10	16.90	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	11.19	10.68	1.02	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.55	13.56	1.99	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.79	12.33	1.48	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	17.71	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	17.50	1.75	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.04	10.97	0.88	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	18.65	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	10.74	1.79	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	12.62	0.97	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	2.28	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.63	16.22	2.49	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	3.37	2.25	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	7.93	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.35	7.10	0.42	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.73	8.01	0.46	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	7.09	6.41	0.84	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.65	6.60	0.68	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.76	8.53	0.55	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	6.66	7.31	0.86	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.53	4.31	0.43	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.60	8.59	0.37	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.12	4.12	0.69	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.73	3.20	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.23	3.92	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.95	3.90	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	29.08	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.93	6.00	1.41	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.06	9.44	0.70	0.00	0.52
Hepatocyte, donor1	11523-119I2	10.90	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	10.77	8.62	6.46	2.15	1.08
Hepatocyte, donor3	11684-122I1	33.13	16.57	5.52	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.04	11.75	1.96	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.31	4.19	0.35	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.98	4.80	0.55	0.00	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	5.01	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	0.00	9.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	5.00	6.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	2.65	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	24.39	6.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.23	5.04	3.15	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	1.55	4.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	40.70	3.23	3.88	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	0.00	4.83	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	36.67	3.26	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	26.45	0.00	2.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.93	1.61	3.21	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	3.69	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	10.38	2.83	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	4.53	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	2.15	6.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	0.00	7.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.25	3.83	3.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	0.00	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.28	0.71	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	28.09	7.10	1.85	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	0.00	7.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	42.42	0.00	2.09	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	0.00	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	3.24	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	45.34	0.87	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	0.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	1.07	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	40.50	0.00	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	2.11	6.34	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.04	3.43	0.49	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	5.27	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	7.67	4.92	0.38	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	8.06	4.88	0.11	0.00	0.00
Keratocytes, donor1	11527-119I6	40.92	10.66	4.13	0.69	1.38
Keratocytes, donor2	11607-120I5	14.06	8.20	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	31.22	14.42	3.75	1.78	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	6.59	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	7.55	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.80	10.84	1.27	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	14.73	3.43	1.01	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.70	11.03	1.42	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	12.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.54	14.32	1.42	0.31	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.75	9.14	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	11.35	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.49	12.72	0.86	0.22	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.85	11.90	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.60	9.86	0.76	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.25	11.82	0.84	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.45	13.05	0.79	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.25	14.15	1.16	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.04	5.55	0.93	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	11.15	1.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.06	14.55	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.03	10.85	1.65	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.24	12.01	0.62	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.05	5.61	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.16	12.63	1.65	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.47	12.18	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	8.49	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	7.22	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	12.12	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.85	9.43	1.35	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.99	13.32	1.06	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	9.85	2.07	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.73	12.14	1.26	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.98	13.98	1.65	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	11.01	2.06	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.55	12.23	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.69	10.92	1.27	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.08	16.48	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	9.92	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.92	12.76	0.87	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.81	14.44	1.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.64	9.64	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.80	11.82	0.82	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.05	14.15	1.93	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.00	16.43	1.83	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.28	16.24	1.82	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.93	16.71	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	4.85	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.47	8.40	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.32	11.82	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	8.49	1.31	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.41	9.42	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.18	9.78	1.11	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.94	5.38	1.54	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.23	10.44	1.79	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	0.00	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	42.19	13.81	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	8.16	2.97	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.47	17.35	4.23	1.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.02	19.69	4.92	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	25.22	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.28	19.06	2.58	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	26.17	9.52	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	29.41	5.43	3.85	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.17	37.52	4.65	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.91	31.51	3.60	0.45	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	41.05	8.40	5.83	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.35	22.60	3.59	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.52	26.11	5.65	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.32	13.33	4.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	37.19	27.51	1.02	0.51	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	32.82	23.48	6.40	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.11	35.71	5.29	0.57	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	32.52	20.25	1.84	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	37.51	16.31	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	39.15	37.48	5.00	1.87	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.63	40.64	2.24	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	10.30	6.18	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.90	34.84	4.94	0.87	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.01	31.99	4.19	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.11	27.66	5.53	0.00	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.82	19.80	6.36	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.98	24.71	6.64	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	17.27	4.61	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	43.36	19.96	5.37	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.74	19.25	2.26	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	23.79	7.38	2.46	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.48	21.24	4.52	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	26.57	21.54	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	34.36	14.94	3.73	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	35.30	17.09	1.49	1.49	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.54	26.28	3.88	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	30.83	9.42	3.43	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.99	23.66	3.66	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.36	16.89	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	7.11	4.98	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	33.34	22.00	4.47	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	14.49	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	6.06	2.69	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	36.67	19.26	5.93	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	3.49	5.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	8.46	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.61	17.21	4.80	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	27.62	7.27	4.36	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	38.33	12.26	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	46.86	21.21	4.93	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	34.81	24.46	4.70	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	16.59	5.53	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.70	20.28	6.31	0.90	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	32.70	24.10	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.98	16.92	10.69	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	45.75	17.99	3.91	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	19.79	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	15.57	7.78	1.04	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	47.26	24.94	6.13	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	15.10	3.91	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.28	19.43	4.86	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	28.93	20.83	4.24	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.85	22.79	2.53	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.12	19.22	8.17	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	35.38	20.27	6.36	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	29.17	19.44	6.68	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	24.21	11.76	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	39.14	23.94	3.04	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	18.07	1.03	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.23	4.84	5.44	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.86	27.89	4.12	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.85	17.59	4.26	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.86	9.19	2.87	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.31	22.11	6.69	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.95	24.76	4.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	25.54	7.38	2.27	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.11	24.13	7.07	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	27.41	21.93	6.26	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.62	10.86	2.09	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	34.38	18.59	7.43	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	16.73	2.01	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.20	11.76	4.81	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.03	12.12	3.23	0.40	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	11.01	2.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	6.22	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	36.47	13.68	5.13	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	10.74	5.37	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	22.98	7.11	3.83	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	33.85	15.59	5.35	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	36.39	3.12	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	5.30	1.99	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	33.26	12.47	8.31	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.26	16.64	1.82	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	23.49	8.99	1.28	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	34.87	11.14	3.01	1.18	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.61	2.69	0.00	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	7.37	2.64	0.42	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	5.38	3.99	0.20	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	4.92	2.61	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.99	1.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	118.64	11.52	14.91	6.10	0.00
Mast cell, donor1	11563-120D6	87.70	43.26	11.25	2.16	0.97
Mast cell, donor2	11565-120D8	184.25	44.28	26.15	6.84	0.59
Mast cell, donor3	11566-120D9	197.21	63.49	25.44	12.16	2.25
Mast cell, donor4	11567-120E1	185.27	81.02	26.06	6.91	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	102.13	36.93	12.20	2.77	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	56.03	30.35	4.09	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	88.57	27.19	9.41	2.18	1.03
Mast cell, expanded, donor8	11941-126A6	98.58	44.18	11.21	2.68	0.84
Melanocyte - dark, donor1	11502-119F8	24.97	13.93	2.98	0.80	0.00
Melanocyte - dark, donor2	11582-120F7	14.54	11.07	1.38	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	106.49	65.41	20.14	3.11	1.74
Melanocyte - light, donor1	11274-116H5	40.20	10.34	8.23	0.94	0.24
Melanocyte - light, donor2	11351-117H1	44.36	6.14	12.97	0.68	0.00
Melanocyte - light, donor3	11423-118G1	26.88	7.81	1.73	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	69.04	27.49	7.50	0.73	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	50.83	44.91	7.53	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	48.48	40.71	10.98	1.87	0.54
Meningeal Cells, donor1	11493-119E8	23.08	6.58	2.23	0.74	0.00
Meningeal Cells, donor2	11573-120E7	23.33	6.16	0.88	1.32	0.00
Meningeal Cells, donor3	11654-122E7	21.68	19.80	1.55	0.08	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.68	11.69	0.29	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.49	10.57	1.71	0.81	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	11.48	0.00	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.97	12.28	2.96	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	19.10	4.02	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.28	5.93	0.44	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	5.11	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.05	2.66	0.61	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.22	5.96	0.69	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.43	3.72	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.97	11.71	1.45	0.53	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.76	4.15	2.08	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	2.56	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.43	20.20	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	9.69	0.94	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	4.35	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	12.20	7.16	0.00	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	11.51	4.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.27	8.60	1.08	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	78.32	17.55	5.40	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	33.99	18.22	5.17	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	41.81	10.60	2.36	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	86.43	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.66	11.78	3.72	1.86	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	25.72	12.65	1.45	0.41	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	4.63	6.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.53	13.01	3.50	1.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	32.58	12.57	2.79	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.78	11.58	2.85	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.51	7.52	2.77	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	8.55	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	12.39	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.80	21.28	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	50.00	1.32	6.58	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.25	13.16	1.70	0.42	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	3.68	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.25	11.03	3.28	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.31	14.55	2.76	0.25	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.24	15.69	1.66	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	38.15	1.11	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	16.35	18.65	1.61	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.40	7.15	1.89	1.05	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.53	6.52	1.02	0.82	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.52	15.66	1.29	1.07	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.56	6.89	3.56	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.02	8.32	1.10	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.79	3.04	1.52	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	4.97	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	9.24	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.00	4.12	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	10.57	2.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	7.60	0.40	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	5.48	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.02	11.01	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	7.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	2.21	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	3.20	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.17	10.66	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	26.44	2.09	4.18	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	46.41	0.00	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	12.65	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	4.38	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.02	4.26	2.49	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.47	7.57	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	26.18	2.08	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	25.06	1.17	2.91	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	9.95	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.11	5.01	2.09	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	4.62	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	23.90	3.41	3.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.59	2.49	2.07	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.85	9.85	1.81	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.88	1.72	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	29.85	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.75	3.47	2.67	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	9.58	3.59	1.80	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.95	1.70	2.40	0.99	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.42	11.15	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.68	4.20	1.11	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.20	2.28	1.14	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.35	10.23	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.26	9.09	1.72	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.07	3.26	3.26	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.94	10.29	2.06	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	18.45	8.07	0.86	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.90	10.72	4.53	3.30	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.14	3.28	2.98	1.49	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	18.83	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	21.39	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.36	25.30	3.94	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	43.13	2.10	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.14	14.23	3.36	1.78	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	15.83	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	30.04	31.17	1.50	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.78	20.77	1.86	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.87	5.88	2.04	0.45	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	23.58	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.25	19.05	4.76	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	49.78	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.71	9.62	3.21	2.14	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	30.91	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	16.16	2.02	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.36	28.25	1.69	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	5.45	0.00	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	3.18	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	16.20	4.86	4.05	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	33.23	3.02	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	14.26	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	25.10	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.93	4.52	0.22	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	8.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	4.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	5.01	2.50	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.29	17.30	2.85	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	3.19	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	4.76	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	135.99	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	4.19	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.67	6.97	2.56	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.65	5.94	0.81	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.23	9.25	4.20	0.63	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	1102.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	4.96	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	11.91	2.17	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.69	9.07	1.13	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.25	7.35	1.63	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.32	8.75	2.37	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	3.71	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	2.40	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.41	19.36	0.66	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	3.25	1.14	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.46	7.76	1.76	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	1.41	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.93	3.68	0.92	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.21	2.57	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.62	12.42	0.69	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	98.61	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	5.79	2.23	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	5.50	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	6.41	0.95	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	3.43	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	586.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	3.67	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	2.71	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	2.38	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	3.71	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.76	5.68	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.50	0.98	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	3.49	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	2.26	1.36	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	3.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.45	2.98	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.68	1.15	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	7.56	1.51	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.50	4.42	1.33	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	3.39	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	270.81	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	3.66	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	2.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	5.75	1.82	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	5.54	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	22.67	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	187.14	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.17	8.20	1.24	0.12	0.00
Myoblast, donor2	11322-117D8	17.45	9.01	0.96	0.58	0.19
Myoblast, donor3	11398-118D3	21.36	5.38	1.85	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	59.39	47.43	9.92	1.31	1.17
Natural Killer Cells, donor1	11230-116C6	198.35	118.39	47.97	11.69	4.00
Natural Killer Cells, donor2	11311-117C6	139.02	131.48	32.57	6.94	4.82
Natural Killer Cells, donor3	11387-118C1	176.51	148.35	47.85	9.02	2.39
Neural stem cells, donor1	11275-116H6	37.38	6.53	2.54	0.36	0.00
Neural stem cells, donor2	11352-117H2	19.26	5.78	0.00	0.00	0.00
Neurons, donor1	11494-119E9	19.34	7.97	4.55	0.00	0.00
Neurons, donor2	11574-120E8	20.48	10.57	0.66	0.00	0.00
Neurons, donor3	11655-122E8	23.02	18.91	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	113.22	37.12	13.92	1.86	0.93
Neutrophils, donor2	11314-117C9	84.07	72.47	11.60	2.90	8.70
Neutrophils, donor3	11390-118C4	140.49	17.10	17.10	1.22	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	19.12	12.82	1.66	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	12.70	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	11.83	6.22	0.80	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	11.43	10.74	1.93	0.28	0.55
Olfactory epithelial cells, donor2	11934-125I8	12.01	12.59	0.87	0.29	0.58
Olfactory epithelial cells, donor3	11935-125I9	8.63	9.19	1.59	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	8.28	5.55	0.68	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	12.04	7.82	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.83	5.96	2.77	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	3.43	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	3.72	1.24	0.62	0.62
Osteoblast, donor1	11277-116H8	7.62	2.93	0.39	0.20	0.00
Osteoblast, donor2	11354-117H4	15.45	9.13	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	17.77	3.20	1.60	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	32.01	22.49	3.96	1.35	0.51
Pericytes, donor1	11491-119E6	8.57	1.89	0.33	0.11	0.00
Pericytes, donor2	11571-120E5	6.34	2.49	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	10.99	4.48	0.61	0.20	0.00
Perineurial Cells, donor1	11499-119F5	14.13	10.62	1.36	0.34	0.23
Perineurial Cells, donor2	11579-120F4	19.97	7.64	1.29	0.74	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	137.38	52.91	20.72	4.78	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	83.99	54.11	12.24	2.45	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	131.23	33.26	21.74	5.44	1.16
Placental Epithelial Cells, donor1	11278-116H9	8.37	1.43	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.21	3.14	1.18	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	11.39	0.95	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.14	18.01	2.25	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.44	6.27	1.57	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	18.91	17.34	2.25	1.13	0.45
Preadipocyte - omental, donor1	11468-119C1	30.58	14.71	3.52	0.96	0.43
Preadipocyte - omental, donor2	11329-117E6	19.64	10.48	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	29.37	25.07	2.72	0.57	0.86
Preadipocyte - perirenal, donor1	11469-119C2	16.73	4.92	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	1.23	1.23	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	20.90	23.91	1.06	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	19.41	10.05	1.19	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	29.99	24.22	2.14	0.37	0.37
Preadipocyte - visceral, donor2	11357-117H7	12.89	14.27	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	24.24	16.61	1.46	0.31	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.44	9.20	1.36	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	4.47	2.84	0.41	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	7.78	4.65	0.31	0.06	0.18
Prostate Stromal Cells, donor1	11254-116F3	23.69	14.35	2.16	0.11	0.57
Prostate Stromal Cells, donor2	11332-117E9	28.87	21.70	1.61	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	19.92	13.76	1.15	0.31	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.03	2.19	0.00	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.70	7.62	0.42	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	12.68	1.52	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.25	6.40	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	12.60	9.00	0.64	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	2.72	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.19	5.12	0.94	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	18.65	6.44	1.11	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.02	3.30	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.66	6.90	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.60	2.22	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.18	12.08	1.61	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	17.71	10.54	1.69	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.69	8.68	0.19	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.26	20.22	2.07	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	20.18	9.38	2.56	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	2.06	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.56	20.07	1.51	0.25	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.50	18.98	4.68	0.53	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	5.36	4.47	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	22.57	2.20	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	5.80	4.06	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	19.76	4.81	1.17	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.97	6.85	2.18	0.40	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	26.66	10.71	1.78	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.46	16.00	1.49	0.25	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.44	11.42	1.75	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.58	15.25	2.08	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	16.29	2.74	1.64	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.76	8.77	1.51	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.27	6.99	2.33	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.06	4.73	0.57	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.89	9.44	1.40	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.02	14.60	1.55	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.76	3.25	0.96	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.25	6.24	1.30	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.62	13.15	0.94	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	19.91	3.18	1.33	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.26	7.98	2.14	0.19	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.35	10.31	1.91	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	16.87	4.59	1.39	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.94	7.29	1.40	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.87	7.35	1.20	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.32	2.73	2.01	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.55	6.38	1.72	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.19	9.40	1.48	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.44	4.48	0.94	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.83	9.33	2.38	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.26	9.35	1.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.14	5.60	0.83	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.47	4.87	1.33	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.53	5.43	3.55	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.96	5.11	1.62	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.52	4.60	2.38	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.85	12.72	3.86	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.21	6.02	0.52	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.94	6.31	2.19	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.79	8.54	1.64	0.16	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.17	2.90	0.85	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.82	11.84	1.33	0.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	24.79	9.06	1.87	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.28	3.32	1.94	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.76	9.76	2.38	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	36.48	8.26	1.21	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.62	6.03	1.60	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	29.70	9.08	1.75	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.99	7.56	2.12	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	14.69	6.85	1.84	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	49.05	10.33	4.80	0.73	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.12	9.73	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.45	5.43	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.24	10.40	1.81	0.23	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.95	16.77	3.29	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.13	6.14	2.83	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.04	9.18	3.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.85	11.42	2.40	0.00	1.20
Schwann Cells, donor1	11498-119F4	8.28	1.69	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	17.01	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	19.28	18.84	1.97	0.66	0.00
Sebocyte, donor1	11220-116B5	12.05	2.74	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	5.06	3.22	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	5.57	4.95	1.03	0.00	0.00
Sertoli Cells, donor1	11255-116F4	11.60	9.94	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	31.07	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.00	15.13	1.58	0.18	0.26
Skeletal Muscle Cells, donor2	11358-117H8	14.46	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	3.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.82	8.64	1.57	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	16.80	5.95	1.64	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	16.78	5.69	0.62	0.62	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.05	13.99	1.76	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.40	8.99	0.57	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.00	9.62	1.69	0.40	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.11	15.00	1.35	0.34	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	6.51	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.29	2.20	0.28	0.14	0.00
Skin - palm, donor1	10286-104F7	21.49	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.89	0.86	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	4.09	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.02	0.91	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.06	4.31	0.14	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	8.44	3.38	0.56	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	27.91	2.75	0.42	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	14.77	4.12	0.97	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.18	5.55	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.45	0.44	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	3.53	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.91	3.54	1.33	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.12	3.94	1.18	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	4.64	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	16.01	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.98	2.53	0.27	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.63	12.86	1.11	0.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.16	1.92	0.64	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.88	8.47	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.29	6.20	1.77	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.96	3.70	0.85	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.46	3.90	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.70	7.00	2.13	0.91	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.93	2.53	2.02	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	1.43	1.91	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.98	8.55	0.88	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.76	7.53	1.51	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.43	6.51	1.15	0.52	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.60	3.87	0.77	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.06	2.09	2.09	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	3.76	0.68	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.04	13.11	1.49	0.16	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.76	6.44	1.71	0.20	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.38	13.20	1.59	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	3.02	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	20.13	10.33	0.53	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.51	9.05	1.73	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.79	17.78	1.63	0.38	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.73	8.37	1.52	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.82	6.03	2.41	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	6.75	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	74.95	3.88	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.44	1.86	1.40	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	8.08	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.15	2.19	0.94	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.37	3.24	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	24.91	6.91	1.50	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.56	13.08	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.23	2.88	1.15	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.40	9.43	2.04	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	3.38	0.38	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.23	12.72	1.68	0.84	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.07	6.70	0.42	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	5.24	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	2.20	1.71	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.08	20.33	3.31	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.95	7.61	1.46	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.58	4.47	1.55	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	9.52	0.79	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	8.93	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	6.47	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	2.56	0.85	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.39	13.39	2.36	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	10.67	6.09	0.76	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	12.78	7.99	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	15.05	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.63	11.46	0.92	0.00	1.38
Synoviocyte, donor1	11291-117A4	15.49	9.59	2.02	0.34	0.17
Synoviocyte, donor2	11368-117I9	17.43	13.75	1.17	0.67	0.17
Synoviocyte, donor3	11440-118H9	10.50	8.49	0.89	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	11.79	5.00	1.43	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	11.89	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.12	3.47	0.23	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.24	3.23	0.07	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	1.55	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	39.74	15.50	4.92	1.23	0.12
Urethra, donor2	10319-105A4	35.97	1.80	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	2.66	1.06	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	2.80	3.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.52	2.29	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	8.02	5.35	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	1267.94	226.00	125.46	7.12	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	1606.88	301.65	134.38	15.73	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	1007.61	240.95	78.04	10.95	17.80
Whole blood (ribopure), donor090325, donation1	12176-128I7	572.98	182.50	65.08	11.71	6.20
Whole blood (ribopure), donor090325, donation2	12177-128I8	472.96	135.96	51.13	7.55	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	972.52	160.35	107.25	11.45	6.25
Whole blood (ribopure), donor090612, donation2	12183-129A5	1172.02	209.26	92.70	11.93	18.36
Whole blood (ribopure), donor090612, donation3	12184-129A6	1111.91	320.43	99.51	11.87	18.26
Wilms' tumor cell line:G-401	10809-111A8	25.91	15.54	2.34	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	19.36	2.64	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	3.07	3.07	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	8.27	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.01	23.46	1.78	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	24.61	11.61	0.70	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	49.86	25.76	5.70	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	73.20	29.39	2.72	0.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	45.25	21.64	3.94	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.27	13.75	6.13	1.27	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.46	41.38	6.81	0.82	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.10	27.32	1.32	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	58.80	49.41	3.68	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	65.23	44.27	3.88	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	9.94	10.49	0.74	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.50	37.41	3.72	0.70	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	46.60	34.43	2.59	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.38	32.73	0.88	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	35.79	8.37	5.11	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	50.17	24.68	7.81	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.93	4.60	4.91	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	39.26	17.92	2.99	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.00	20.93	3.94	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	37.55	14.20	4.57	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.17	15.15	2.90	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	59.04	12.01	5.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	159.81	24.16	13.01	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.02	29.38	4.14	0.38	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.89	12.65	5.23	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	131.21	35.61	7.50	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.13	2.35	1.18	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	37.23	10.70	4.50	0.62	0.16
adipose, donor1	10184-103D4	55.71	43.98	3.52	0.00	0.59
adipose, donor2	10185-103D5	16.63	11.76	0.41	0.00	0.00
adipose, donor3	10186-103D6	23.96	13.07	0.00	0.00	0.27
adipose, donor4	10187-103D7	32.07	36.40	4.33	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	11.05	2.37	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	25.61	12.81	1.07	0.13	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.51	9.65	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	6.26	2.32	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	10.48	1.35	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	5.30	1.77	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	81.82	42.69	11.86	2.37	1.19
amygdala, adult, donor10252	10151-102I7	219.39	88.20	21.09	1.82	2.23
amygdala, newborn, donor10223	10360-105E9	27.76	12.59	2.26	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	19.99	15.02	1.91	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.00	11.69	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	13.70	4.01	2.34	0.00	0.00
aorta, adult, pool1	10052-101G7	51.58	20.20	4.31	1.77	1.37
appendix, adult	10189-103D9	90.82	15.52	12.81	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.29	6.19	1.38	0.69	0.00
artery, adult	10190-103E1	14.95	8.15	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	8.55	4.20	0.14	0.14	0.00
b cell line:RPMI1788	10427-106D4	68.40	42.38	4.61	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.70	9.16	0.83	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.09	7.84	1.29	0.30	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	10.71	11.21	0.67	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	48.09	30.76	6.71	0.56	1.68
bladder, adult, pool1	10011-101C2	46.28	10.43	3.59	1.63	0.00
blood, adult, pool1	10053-101G8	728.61	263.54	59.79	11.07	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	11.99	0.86	0.00	1.71
bone marrow, adult	10192-103E3	37.12	13.50	4.05	1.35	0.67
brain, adult, donor1	10084-102B3	114.81	79.96	17.43	1.03	3.08
brain, adult, pool1	10012-101C3	262.81	94.88	31.40	3.90	1.11
brain, fetal, pool1	10085-102B4	37.40	16.03	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	60.13	15.86	10.90	1.98	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.97	5.24	1.87	0.75	0.12
breast, adult, donor1	10080-102A8	25.89	3.16	2.53	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.35	7.62	0.25	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.15	9.90	0.93	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	28.55	36.14	0.92	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.60	4.12	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	17.40	14.58	1.88	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	28.44	3.50	2.73	0.88	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	6.34	9.82	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.36	5.32	1.06	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	222.21	55.26	28.78	3.45	3.45
caudate nucleus, adult, donor10252	10164-103B2	151.60	52.21	12.55	1.51	0.84
caudate nucleus, adult, donor10258	10379-105H1	118.44	24.45	9.17	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	30.76	15.02	3.66	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	87.40	11.65	5.83	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	64.48	23.27	5.98	0.43	0.64
cerebellum, adult, pool1	10083-102B2	60.02	25.18	6.21	0.34	1.72
cerebellum, newborn, donor10223	10357-105E6	47.33	19.93	6.64	0.83	0.00
cerebral meninges, adult	10188-103D8	112.20	12.10	9.33	2.27	0.25
cerebrospinal fluid, donor2	10294-104G6	55.55	20.46	7.31	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.50	8.48	0.72	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	11.27	6.46	1.66	0.17	0.00
cervix, adult, pool1	10013-101C4	40.84	14.49	4.41	0.94	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	26.75	16.58	3.07	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	1.31	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.94	5.97	0.50	0.25	0.12
choriocarcinoma cell line:SCH	10785-110H2	24.64	18.85	2.09	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	4.74	0.71	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	5.70	3.42	0.85	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	11.93	4.77	1.59	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	8.79	1.65	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	33.32	4.04	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	78.18	49.56	3.27	0.58	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	61.24	21.54	9.08	1.69	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.05	9.50	1.80	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	38.70	9.68	3.39	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.58	8.96	3.87	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	63.90	30.33	5.89	1.18	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	68.54	22.67	3.39	1.56	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.60	37.26	2.29	0.00	1.83
clear cell carcinoma cell line:TEN	10636-108I6	18.39	13.19	2.95	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	16.29	8.24	1.28	0.73	0.18
colon carcinoma cell line:COLO-320	10420-106C6	15.96	8.36	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	22.61	4.76	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	35.37	11.05	4.00	1.41	0.12
colon, fetal, donor1	10070-101I7	25.96	10.51	3.71	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	481.27	0.00	13.75	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.47	5.52	1.27	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.57	9.06	0.60	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	13.11	9.02	0.71	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	807.99	183.75	86.90	7.74	2.54
cruciate ligament, donor2	10295-104G7	19.45	6.48	4.86	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	20.87	4.82	0.80	0.00	0.00
diencephalon, adult	10193-103E4	294.71	133.67	37.68	3.36	4.56
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	27.78	19.98	1.38	0.00	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.77	4.36	1.03	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.80	6.98	0.24	0.24	0.00
ductus deferens, adult	10196-103E7	14.45	4.98	1.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	27.36	7.20	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.75	13.24	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	61.86	12.39	9.41	3.22	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.11	2.44	1.11	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.78	11.89	1.15	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	5.45	3.63	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.11	2.78	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.07	6.70	1.01	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.55	11.96	2.54	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4.82	4.82	0.80	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	8.67	2.78	0.11	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	15.07	8.80	1.98	0.22	0.00
epididymis, adult	10197-103E8	25.75	11.30	2.51	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.26	3.37	0.00	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.90	1.57	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	7.34	7.60	0.52	0.26	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	6.00	6.99	0.49	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	7.62	7.06	0.67	0.22	0.00
esophagus, adult, pool1	10015-101C6	27.08	7.22	2.97	0.74	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	7.64	2.38	0.00	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	31.39	12.07	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	13.39	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	32.10	9.17	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	8.74	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	20.34	8.90	2.80	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	27.82	21.67	2.31	0.77	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.78	15.91	2.14	0.47	0.71
frontal lobe, adult, pool1	10040-101F4	212.42	55.73	22.71	3.10	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.41	5.40	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	25.33	11.43	1.10	0.00	0.37
gall bladder, adult	10198-103E9	48.77	9.42	4.35	1.21	0.48
gamma delta positive T cells, donor1	11937-126A2	224.94	118.64	46.17	9.13	2.15
gamma delta positive T cells, donor2	11938-126A3	227.08	150.89	55.65	10.46	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.03	5.49	0.63	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	12.77	3.48	0.58	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	10.49	5.41	0.66	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	21.97	5.49	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	21.25	6.40	2.06	1.14	0.69
giant cell carcinoma cell line:LU65	10487-107B1	18.59	14.11	2.18	0.23	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	18.05	7.84	0.42	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.49	2.24	0.50	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.94	13.93	2.32	0.42	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.31	9.41	4.35	0.42	0.70
glioblastoma cell line:T98G	10485-107A8	10.26	7.40	1.88	0.22	0.11
glioma cell line:GI-1	10413-106B8	29.87	16.40	2.93	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	520.44	109.34	91.11	2.92	1.46
globus pallidus, adult, donor10252	10161-103A8	816.98	392.50	86.90	8.06	4.39
globus pallidus, adult, donor10258	10367-105F7	518.93	331.35	78.04	2.74	10.95
globus pallidus, newborn, donor10223	10364-105F4	65.02	41.57	10.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	315.68	0.00	17.13	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.32	8.00	2.24	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	22.04	10.56	2.30	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	18.29	9.60	2.29	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	18.03	1.93	2.58	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	2.87	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	27.43	5.49	2.74	0.69	0.00
hIPS, biol_rep3	14382-156B8	109.24	29.79	23.17	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	16.09	15.23	1.15	0.00	0.57
heart - mitral valve, adult	10205-103F7	20.33	6.28	3.89	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	21.44	9.15	2.35	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	36.64	9.16	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	10.81	3.26	0.82	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	5.11	5.96	1.28	0.43	0.00
heart, adult, pool1	10016-101C7	28.52	4.60	2.76	0.46	0.00
heart, fetal, pool1	10046-101G1	34.30	6.57	3.70	0.82	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	6.17	0.62	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	1.19	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	23.87	16.57	1.99	0.11	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.64	16.02	1.94	0.24	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	23.24	19.20	1.62	0.40	0.61
hepatoma cell line:Li-7	10484-107A7	23.24	16.68	3.56	0.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	87.13	63.32	7.94	1.21	0.90
hippocampus - adult, donor10196	10169-103B7	141.95	59.62	16.09	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	285.74	117.77	21.63	3.88	2.04
hippocampus, adult, donor10258	10374-105G5	58.26	22.41	6.47	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	21.15	9.87	3.17	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	37.84	32.96	2.44	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.21	27.29	1.77	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.93	19.80	3.05	0.25	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	16.92	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	31.50	22.46	1.29	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.44	17.08	1.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	12.55	1.46	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	26.93	13.57	0.65	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.02	14.18	0.42	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.34	9.00	0.24	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.52	12.86	0.64	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	18.18	10.77	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.82	15.49	2.97	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	29.97	14.25	0.49	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	29.67	20.95	1.75	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.69	12.41	0.57	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.73	9.59	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	32.98	11.49	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.13	3.77	0.57	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.46	6.37	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	3.76	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.10	8.49	0.98	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.77	4.64	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	16.14	7.47	0.90	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.46	19.58	1.66	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.68	17.40	1.71	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.93	22.46	3.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.96	11.62	0.70	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.15	11.72	0.63	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.54	9.99	0.61	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.45	7.76	1.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	6.64	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.52	8.21	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	11.76	7.41	1.28	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	15.90	7.57	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.43	8.74	0.34	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.43	14.73	1.45	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	25.85	17.38	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.34	22.93	1.46	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.53	10.39	2.14	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	133.38	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	32.76	25.15	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.61	7.66	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	18.46	9.41	0.72	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	14.59	7.47	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	8.35	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	17.33	6.23	0.95	0.41	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.85	7.81	0.27	0.27	0.27
immature langerhans cells, donor1	11904-125F5	15.01	4.60	1.94	0.24	0.24
immature langerhans cells, donor2	11905-125F6	6.34	5.54	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	186.90	41.64	18.74	3.31	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	2.28	1.30	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	27.13	9.91	4.31	1.40	0.10
kidney, fetal, pool1	10045-101F9	29.78	4.10	2.33	0.50	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	39.77	15.76	3.27	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.67	4.42	0.00	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.17	5.69	2.75	0.37	0.00
left atrium, adult, donor1	10079-102A7	15.80	4.36	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	8.09	4.55	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	8.76	2.46	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	10.06	7.18	1.08	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	10.87	7.07	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	12.14	8.26	0.73	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	6.27	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	106.25	57.49	6.38	0.24	0.59
liposarcoma cell line:KMLS-1	10782-110G8	15.00	6.87	1.56	0.78	0.00
liposarcoma cell line:SW 872	10726-110A6	14.86	5.00	2.07	0.61	0.12
liver, adult, pool1	10018-101C9	18.96	6.64	2.27	0.65	0.32
liver, fetal, pool1	10086-102B5	50.80	11.29	5.64	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	359.60	65.91	43.31	3.79	1.31
locus coeruleus, adult, donor10252	10165-103B3	346.59	185.29	24.73	2.58	3.51
locus coeruleus, adult, donor10258	10375-105G6	166.74	83.23	23.14	1.97	1.13
locus coeruleus, newborn, donor10223	10362-105F2	40.80	26.50	2.52	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	17.16	8.58	1.11	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	22.06	2.07	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	54.31	6.06	3.30	0.53	0.26
lung, adult, pool1	10019-101D1	55.87	11.69	5.32	1.30	0.00
lung, fetal, donor1	10068-101I5	68.21	10.85	6.56	0.86	0.86
lung, right lower lobe, adult, donor1	10075-102A3	39.41	20.62	3.67	1.37	0.92
lymph node, adult, donor1	10077-102A5	70.06	27.93	10.89	2.84	0.47
lymphangiectasia cell line:DS-1	10727-110A7	28.05	15.34	2.85	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.85	24.60	6.94	1.51	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	11.89	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	19.54	3.55	2.22	0.89	0.00
mature adipocyte, donor2	12232-129F9	17.43	3.32	1.45	0.21	0.21
mature adipocyte, donor3	12233-129G1	15.41	1.90	0.71	0.24	0.00
mature adipocyte, donor4	12234-129G2	11.58	2.90	0.79	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.20	3.81	0.71	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	116.19	45.12	10.15	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	245.70	93.24	23.54	2.39	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	103.88	53.05	11.75	0.95	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	33.27	19.19	4.69	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	172.29	30.38	17.21	1.01	3.21
medial temporal gyrus, adult, donor10252	10156-103A3	311.33	115.03	29.50	2.76	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	78.98	28.89	7.71	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	9315.50	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.71	18.31	5.03	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	196.64	73.33	25.31	3.89	3.24
medulla oblongata, adult, donor10252	10155-103A2	303.26	129.11	26.01	2.48	2.79
medulla oblongata, adult, pool1	10038-101F2	387.97	87.42	47.92	5.31	1.31
medulla oblongata, newborn, donor10223	10361-105F1	80.55	51.38	11.80	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	197.72	75.28	11.51	0.89	2.44
medulloblastoma cell line:ONS-76	10759-110E3	19.20	4.04	0.98	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	73.89	44.27	11.36	2.30	1.29
melanoma cell line:G-361	10465-106H6	21.17	11.94	2.44	0.54	0.81
meningioma cell line:HKBMM	10691-109F7	11.40	11.76	1.45	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	10.57	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	19.18	5.44	0.78	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.34	12.27	0.92	0.46	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	7.82	1.27	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	10.77	12.42	1.66	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.75	9.13	1.83	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.75	6.93	0.96	0.58	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	11.11	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	18.19	9.10	3.09	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	28.29	12.54	3.11	0.35	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.01	5.17	0.66	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.42	5.81	0.68	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.38	7.26	1.14	0.57	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.88	7.25	1.32	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.87	4.70	0.83	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	11.17	10.12	1.05	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.31	9.19	1.43	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.35	7.91	1.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.24	3.62	0.62	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.16	4.10	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	12.59	5.45	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.06	5.08	0.90	0.45	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.82	4.90	0.53	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.04	7.73	0.74	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.30	6.87	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	21.47	2.53	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.20	16.44	5.48	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.32	22.76	1.02	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	25.13	22.25	2.09	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.57	20.64	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	21.65	25.65	1.41	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.71	20.31	1.35	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.36	25.94	2.36	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.61	20.85	2.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.55	17.02	2.88	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.98	18.07	2.90	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	24.52	22.59	3.12	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.73	22.73	5.87	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.79	15.10	2.01	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	18.83	17.60	2.05	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.63	12.46	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	16.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.03	14.94	3.25	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	17.46	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	18.12	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	19.63	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	17.88	0.78	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	16.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	13.91	1.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	19.07	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	13.05	2.96	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	17.06	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	9.50	3.80	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.69	4.83	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	15.04	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	13.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	6.11	0.81	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	13.51	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.25	10.02	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.66	10.29	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	6.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	7.70	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	9.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.90	6.93	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	8.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	10.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	10.88	1.21	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	23.99	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	6.34	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	5.46	2.43	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	22.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	14.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.54	5.56	0.79	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.81	4.87	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	12.22	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	3.09	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.97	30.24	3.07	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.26	3.24	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.24	4.93	1.44	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	9.53	6.35	0.68	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	18.09	12.47	0.98	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	16.16	9.30	2.44	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	9.99	10.78	1.05	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	7.32	5.45	0.68	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	9.10	5.81	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	10.77	9.32	0.83	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	9.94	6.29	1.49	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	18.46	13.03	0.36	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	39.97	26.65	2.90	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	76.34	57.76	8.40	0.25	1.53
mesothelioma cell line:No36	10857-111G2	7.18	4.57	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	13.55	9.21	1.63	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	42.03	20.15	2.69	1.54	0.38
migratory langerhans cells, donor2	11902-125F3	56.91	15.51	6.11	1.95	0.85
migratory langerhans cells, donor3	11903-125F4	63.72	18.13	4.67	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.26	19.59	2.61	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.70	25.43	1.70	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	44.69	15.43	4.38	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	20.93	7.99	0.76	0.76	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.27	31.23	5.17	0.55	0.37
myeloma cell line:PCM6	10474-106I6	54.75	45.66	5.34	0.59	2.17
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	4.57	0.00	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.50	10.20	1.57	1.18	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.13	3.57	0.11	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.97	4.41	0.07	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	11.04	3.31	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	26.69	13.34	2.30	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	19.27	12.16	0.75	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	6.75	4.01	0.84	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	17.89	5.96	1.12	0.19	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.37	7.59	0.24	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	7.60	6.97	0.79	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	5.64	5.23	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	1.91	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	16.50	10.38	1.06	0.80	0.53
neutrophil PMN, donor1	12133-128D9	475.99	0.00	74.37	29.75	0.00
neutrophil PMN, donor2	12137-128E4	106.25	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	90.31	32.47	3.72	0.68	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.26	8.98	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.67	7.88	0.00	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	257.78	53.24	28.59	3.19	0.75
occipital cortex - adult, donor10196	10172-103C1	187.49	26.78	30.91	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	366.85	149.48	36.77	3.76	1.07
occipital cortex, newborn, donor10223	10355-105E4	39.67	9.83	4.73	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	205.46	95.78	23.09	4.20	2.36
occipital lobe, fetal, donor1	10073-102A1	47.63	15.88	1.72	0.86	0.00
occipital pole, adult, pool1	10036-101E9	187.41	35.01	22.63	3.31	0.47
olfactory region, adult	10195-103E6	188.00	67.25	16.81	1.72	4.01
optic nerve, donor1	10277-104E7	1114.58	230.12	134.07	18.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.45	12.07	3.65	0.80	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.85	7.69	0.14	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.79	4.57	0.34	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.43	3.12	0.46	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	18.52	5.29	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	56.99	13.08	8.41	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	30.11	12.94	2.54	0.64	0.42
ovary, adult, pool1	10020-101D2	27.87	3.84	2.88	0.96	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.05	8.43	1.65	0.37	0.18
pancreas, adult, donor1	10049-101G4	17.87	9.41	0.94	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.27	1.96	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	10.22	10.73	2.38	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.04	7.95	0.99	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	228.99	50.25	28.37	3.75	1.37
parietal cortex, adult, donor10258	10373-105G4	88.08	29.36	12.48	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	240.76	70.54	31.04	0.94	3.76
parietal lobe, adult, donor10252	10157-103A4	183.85	83.23	17.10	2.00	2.00
parietal lobe, adult, pool1	10034-101E7	249.47	51.02	29.34	3.44	0.53
parietal lobe, fetal, donor1	10072-101I9	35.88	13.58	0.97	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	37.01	11.96	4.49	0.75	0.75
parotid gland, adult	10199-103F1	11.10	7.40	3.08	0.62	0.62
penis, adult	10200-103F2	29.00	11.82	1.61	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.25	2.05	0.19	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.60	5.39	0.58	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	21.93	1.29	2.58	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	33.16	7.70	1.78	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	15.68	4.39	3.76	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	23.27	5.06	3.04	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	38.57	8.86	2.08	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	21.28	8.51	2.55	0.00	0.00
placenta, adult, pool1	10021-101D3	34.29	7.20	2.26	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	59.72	34.30	7.02	0.93	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.70	12.30	2.49	1.09	0.00
pons, adult, pool1	10033-101E6	301.15	68.17	32.71	4.13	1.20
postcentral gyrus, adult, pool1	10032-101E5	209.05	55.62	25.72	3.75	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	328.35	2.09	12.55	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.92	14.13	1.02	0.00	0.87
prostate cancer cell line:PC-3	10439-106E7	26.32	10.16	1.63	0.54	0.54
prostate, adult, pool1	10022-101D4	30.20	5.99	3.36	0.73	0.27
putamen, adult, donor10196	10176-103C5	172.33	66.81	9.91	2.36	2.12
putamen, adult, donor10252	10152-102I8	368.62	103.92	49.02	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	9.84	5.46	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	142.31	46.15	17.15	1.93	1.45
putamen, newborn, donor10223	10365-105F5	29.99	50.98	3.00	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	21.53	1.75	0.58	0.00	0.00
rectum, fetal, donor1	10067-101I4	33.38	20.86	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.25	24.80	3.18	1.27	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	35.62	28.17	1.66	0.00	0.83
retina, adult, pool1	10030-101E3	57.95	12.52	9.34	2.39	0.20
retinoblastoma cell line:Y79	10475-106I7	13.51	4.94	0.52	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.31	6.15	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	11.25	3.09	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	3.79	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	7.61	2.59	0.49	0.16	0.32
salivary acinar cells, donor2	11772-123I8	7.02	3.17	0.41	0.28	0.14
salivary acinar cells, donor3	11773-123I9	18.54	2.65	1.99	1.32	0.00
salivary gland, adult, pool1	10093-102C3	11.44	4.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.49	9.27	2.28	0.34	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.04	8.11	2.00	0.47	0.47
seminal vesicle, adult	10201-103F3	14.28	3.70	2.12	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.07	3.89	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	6.29	1.51	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	17.06	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5.37	3.63	0.40	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	13.15	6.85	2.21	0.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.52	3.87	0.77	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	2.84	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	13.55	3.60	0.72	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	24.12	10.05	3.02	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	23.36	8.84	1.89	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.01	6.34	0.67	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	20.17	9.77	3.78	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.48	8.87	0.58	0.00	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	8.24	3.13	0.66	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.36	4.34	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.66	7.19	5.23	1.31	0.22
small intestine, adult, pool1	10024-101D6	39.42	10.03	6.57	1.31	0.24
small intestine, fetal, donor1	10064-101I1	19.16	16.22	1.72	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	4.62	4.10	0.51	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	33.60	14.73	3.36	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	13.94	1.07	1.34	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	377.14	69.51	47.49	3.90	2.29
spinal cord, adult, donor10252	10159-103A6	389.15	123.01	35.88	3.55	3.15
spinal cord, adult, donor10258	10369-105F9	148.74	59.49	27.67	1.38	2.77
spinal cord, fetal, donor1	10056-101H2	75.01	43.30	10.98	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	246.60	113.88	35.82	5.51	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.99	7.17	2.54	0.45	0.15
spleen, adult, pool1	10025-101D7	116.08	29.19	14.10	3.19	0.33
spleen, fetal, pool1	10044-101F8	129.67	20.10	12.32	1.67	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	57.76	47.41	6.11	0.93	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.72	4.94	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	6.29	2.45	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.16	2.35	0.78	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.73	12.83	2.70	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	14.40	2.54	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.46	6.35	5.08	0.85	0.00
stomach, fetal, donor1	10062-101H8	39.52	9.61	6.41	1.07	0.00
submaxillary gland, adult	10202-103F4	21.08	7.98	3.99	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	488.47	17259.18	162.82	0.00	597.02
substantia nigra, adult, donor10252	10158-103A5	614.81	407.73	52.34	4.36	10.39
substantia nigra, adult, donor10258	10371-105G2	109.66	31.04	20.69	1.03	2.07
substantia nigra, newborn, donor10223	10358-105E7	119.41	61.47	19.08	0.00	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.91	19.95	3.44	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	206.84	42.72	25.60	2.71	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	35.61	17.09	2.14	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.09	12.31	0.88	0.00	0.00
tenocyte, donor1	11763-123H8	22.34	12.57	2.44	1.75	0.70
tenocyte, donor2	11765-123I1	14.88	17.55	1.14	0.76	0.38
tenocyte, donor3	11768-123I4	14.09	13.34	1.48	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	30.08	20.91	1.19	0.00	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	11.10	7.24	1.39	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	17.05	12.24	0.46	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.98	9.65	1.27	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.59	2.27	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.05	4.36	1.09	0.44	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.66	8.47	0.65	0.65	0.98
testis, adult, pool1	10026-101D8	27.49	7.95	3.44	1.18	0.21
testis, adult, pool2	10096-102C6	25.71	9.47	3.61	2.26	0.90
thalamus - adult, donor10196	10168-103B6	516.67	194.30	44.16	5.52	3.31
thalamus, adult, donor10252	10154-103A1	623.41	293.19	52.82	4.53	6.10
thalamus, adult, donor10258, tech_rep1	10370-105G1	135.49	30.79	24.63	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	158.43	109.02	14.33	1.81	1.15
thalamus, newborn, donor10223	10366-105F6	14.38	20.14	0.58	0.00	0.58
throat, adult	10209-103G2	27.71	10.24	3.50	0.50	0.25
throat, fetal, donor1	10061-101H7	25.29	13.10	2.13	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	11.13	4.37	0.40	0.20	0.40
thymus, adult, pool1	10027-101D9	94.15	12.53	3.88	0.40	0.30
thymus, fetal, pool1	10043-101F7	116.68	15.90	5.92	1.04	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.13	15.56	2.26	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	26.82	21.23	4.89	1.40	0.56
thyroid, adult, pool1	10028-101E1	21.37	6.72	2.05	0.56	0.28
thyroid, fetal, donor1	10060-101H6	20.83	8.70	1.85	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	11.86	4.65	0.70	0.23	0.00
tongue, fetal, donor1	10059-101H5	10.64	6.70	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	97.57	19.63	10.62	2.91	0.60
trachea, adult, pool1	10029-101E2	31.57	8.67	4.17	0.82	0.33
trachea, fetal, donor1	10058-101H4	25.01	11.54	2.31	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.46	7.79	0.71	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	12.06	4.56	1.62	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.01	29.77	4.86	0.00	1.25
tridermal teratoma cell line:HGRT	10694-109G1	36.15	5.71	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.12	6.26	1.35	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	14.61	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	36.34	7.68	4.27	0.51	0.17
uterus, fetal, donor1	10055-101H1	40.44	20.48	1.54	0.00	0.51
vagina, adult	10204-103F6	40.71	5.82	6.46	1.29	0.00
vein, adult	10191-103E2	60.94	19.51	7.23	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	59.28	36.32	3.74	0.53	0.53